NVOS Novo Integrated Sciences Inc

Price (delayed)

$0.648

Market cap

$12.35M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.28

Enterprise value

$15.05M

Novo Integrated Sciences, Inc. is a U.S. based provider of multidisciplinary primary care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science. The company ...

Highlights
The debt has declined by 14% since the previous quarter
The net income has plunged by 101% from the previous quarter but it has grown by 25% YoY
NVOS's EPS has shrunk by 100% QoQ but it has soared by 86% YoY
The gross margin has dropped by 89% year-on-year and by 6% since the previous quarter
NVOS's equity has dropped by 63% year-on-year and by 55% since the previous quarter

Key stats

What are the main financial stats of NVOS
Market
Shares outstanding
19.05M
Market cap
$12.35M
Enterprise value
$15.05M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.24
Price to sales (P/S)
0.9
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.11
Earnings
Revenue
$13.52M
EBIT
-$23.75M
EBITDA
-$20.83M
Free cash flow
-$4.78M
Per share
EPS
-$1.28
Free cash flow per share
-$0.26
Book value per share
$0.52
Revenue per share
$0.72
TBVPS
$0.7
Balance sheet
Total assets
$35.33M
Total liabilities
$25.66M
Debt
$4.24M
Equity
$9.96M
Working capital
-$16.52M
Liquidity
Debt to equity
0.43
Current ratio
0.27
Quick ratio
0.21
Net debt/EBITDA
-0.13
Margins
EBITDA margin
-154.1%
Gross margin
37.7%
Net margin
-180%
Operating margin
-77.5%
Efficiency
Return on assets
-68%
Return on equity
-120.8%
Return on invested capital
-753.5%
Return on capital employed
-187.7%
Return on sales
-175.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NVOS stock price

How has the Novo Integrated Sciences stock price performed over time
Intraday
-3.28%
1 week
15.71%
1 month
-20.98%
1 year
-42.91%
YTD
-21.07%
QTD
-13.6%

Financial performance

How have Novo Integrated Sciences's revenue and profit performed over time
Revenue
$13.52M
Gross profit
$5.09M
Operating income
-$10.47M
Net income
-$24.33M
Gross margin
37.7%
Net margin
-180%
The net margin has dropped by 103% since the previous quarter but it has soared by 94% year-on-year
The net income has plunged by 101% from the previous quarter but it has grown by 25% YoY
Novo Integrated Sciences's operating margin has surged by 97% YoY but it has decreased by 13% QoQ
The gross margin has dropped by 89% year-on-year and by 6% since the previous quarter

Growth

What is Novo Integrated Sciences's growth rate over time

Valuation

What is Novo Integrated Sciences stock price valuation
P/E
N/A
P/B
1.24
P/S
0.9
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.11
NVOS's EPS has shrunk by 100% QoQ but it has soared by 86% YoY
NVOS's equity has dropped by 63% year-on-year and by 55% since the previous quarter
The price to book (P/B) is 24% higher than the last 4 quarters average of 1.0
The P/S is 25% below the last 4 quarters average of 1.2

Efficiency

How efficient is Novo Integrated Sciences business performance
Novo Integrated Sciences's ROE has plunged by 143% from the previous quarter but it has increased by 10% YoY
The ROIC has plunged by 120% YoY
NVOS's ROS has shrunk by 105% QoQ but it has soared by 94% YoY
The company's return on assets has shrunk by 102% QoQ but it rose by 21% YoY

Dividends

What is NVOS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NVOS.

Financial health

How did Novo Integrated Sciences financials performed over time
The total assets is 38% more than the total liabilities
Novo Integrated Sciences's total liabilities has surged by 171% YoY and by 97% QoQ
The current ratio has dropped by 58% year-on-year and by 46% since the previous quarter
The debt is 57% smaller than the equity
The company's debt to equity has surged by 169% YoY and by 95% QoQ
NVOS's equity has dropped by 63% year-on-year and by 55% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.